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ABSTRACT
Obesity is a condition involving low-level chronic inflammation as indicated by increased 
levels of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-a), interleukin (IL) and 
other inflammatory markers in the blood. Some endocrine mediators, such as paracrine and 
autocrine play an important role in regulating the function of adipocytes, especially related 
to insulin sensitivity. The purpose of this study is to determine the level CRP, TNF-a, IL-6, 
resistin and insulin resistance in the obese Javanese population. This was a preliminary 
study involving 120 people, consisting of 60 obese subjects and 60 non obese subjects 
as controls. Lipid profiles, CRP, TNF-a, IL-6, resistin levels were determined with ELISA 
methods, whereas insulin resistance was calculated by HOMA IR index. The study found 
that the glucose, insulin, CRP levels and HOMA-IR of obese subjects were significantly 
higher than those non obese subjects (p<0.05). However, the TNF-a, IL-6 and resistin 
levels were not significantly different between obese and non obese subjects (p>0.05). 
In conclusion, the CRP levels ad insulin resistance in obese Javanese population were 
higher compared with those non obese. 
ABSTRAK
Obesitas merupakan suatu kondisi yang melibatkan peradangan kronis tingkat rendah 
seperti ditunjukkan oleh peningkatan kadar protein C-reaktif (CRP), tumor necrosis factor 
alpha (TNF-a), interleukin (IL) dan penanda inflamasi lainnya dalam darah. Beberapa 
mediator endokrin, seperti parakrin dan autokrin berperan penting dalam mengatur fungsi 
adiposit, terutama yang berkaitan dengan sensitivitas insulin. Tujuan penelitian ini adalah 
untuk menetapkan kadar CRP, TNF-a, IL-6, resistin dan resistensi insulin pada populasi 
Jawa obes. Penelitian ini merupakan studi pendahuluan yang melipatkan 120 subjek, 
terdiri dari 60 subjek obes 60 tidak obes sebagai kontrol. Profil lipid, kadar CRP, TNF-a, 
IL-6, dan resistin diukur dengan metode ELISA, sedangkan resistensi insulin dihitung 
dengan indeks IR HOMA. Dari penelitian ini ditemukan bahwa kadar glukosa, insulin, 
CRP, dan HOMA-IR subjek obes lebih tinggi secara bermakna dibandingkan subjek non 
obes (p<0,05). Namun demikian kadar TNF-a, IL-6 dan resistin tidak berbeda bermakna 
antara kelompok subjek obes dan non obes (p> 0,05). Dapat disimpulkan, kadar CRP dan 
resistensi insulin pada populasi Jawa obes lebi tinggi dibandingkan dengan mereka yang 
tidak obes.
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INTRODUCTION
In 2013, Ministry of Health, Republic of 
Indonesia reported 18.8% of population in 12 
major cities in Indonesia were overweight and 
3.7% of them were obese.1 Obesity involves 
a state of low-level chronic inflammation as 
indicated by increased levels of C-reactive 
protein (CRP), tumor necrosis factor-alpha 
(TNF-α), interleukin, resistin and other 
inflammatory markers in the blood. Some 
endocrine mediators such as, paracrine and 
autocrine derived from adipose tissue play 
an important role in regulating the function 
of adipocytes, especially those related to 
insulin. Significant complications of obesity, 
especially insulin resistance include many 
of the risk factors of type 2 diabetes mellitus 
(type 2 DM).2,3.
Adipokines (adipocitokines) include 
TNF-α,  IL-6, resistin and CRP are secreted 
primarily in adipose cells in mice and 
mononuclear cells in humans as a result of 
inflammation process. Adipokines play an 
important role in regulating energy, glucose 
and fat homeostasis and maintain fasting 
blood glucose levels by modulating hepatic 
insulin.4 Low levels of adipokines are already 
in circulation, but there are increased levels in 
people with insulin resistance, type 2 DM and 
cardiovascular disease. Hypoadiponectinemia 
increases the risk of coronary artery disease, 
and shows that adipokine plays a role in 
metabolic syndromes.5 It was reported that the 
increase of risistin levels not only stimulates 
the expression but also degrades of low density 
lipoprotein-cholesterol (LDL-cholesterol) 
receptors in liver cells.6
Resistin is an antagonist of insulin 
and mediates insulin-signaling pathways 
playing a role in the pathogenesis of insulin 
resistance. Excessive resistin expression in 
adipose tissues of obese people might act to 
mediate the modulation of insulin sensitivity.7 
Experiments with exogenous administration 
of TNF-α in animals induced insulin 
resistance while decreasing TNF-α improve 
insulin sensitivity. There is increasing levels 
of TNF-α in patients with diabetes correlated 
with Body Mass Index (BMI) and Homeostatic 
Model Assessment of Insulin Resistance 
(HOMA-IR). This relationship was stronger 
in women than men.8 Over production of 
cytokine is correlated with the initial onset 
of inflammation and is a prognostic indicator 
of inflammation due to obesity and metabolic 
syndromes. IL-6 as a mediator of inflammatory, 
acting as an autocrine regulator of adipocytes 
may cause the negative effects on metabolic 
processe.9 This was a preliminary study in 
order to evaluate the levels of adipokines and 
insulin resistance in obese Javanese people in 
Yogyakarta Special Region, Indonesia.
MATERIALS AND METHODS
Subjects
This was an observational study with a 
cross sectional design in order to compare 
the adipokines levels and insulin resistance 
in obese with non obese Javanese people in 
Indonesia. One hundred and twenty subjects 
consisting 60 obese subjects and 60 non 
obese subjects were involved in this study. 
Subjects with body mass index (BMI) > 25 
for obese and 18.5 to 23 for non obese with 
the ages from 18 to years were included in 
this study. Subjects who taking corticosteroid 
and antibiotics were excluded from this study. 
The protocol of this study has been approved 
by the Medical Health Research Ethics 
Committee, Faculty of Medicine, Universitas 
Gadjah Mada, Yogyakarta.
Protocol 
Each subject received written and verbal 
explanations concerning the background, 
objectives and benefit of the study before 
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signing an informed consent form. After 
obtaining written informed consent, all 
subjects were screened through a detailed 
questionnaires, medical history and physical 
examination. Age, sex, height, weight, BMI, 
waist to hip ratio, blood pressure, family 
history and present medications were recorded 
for each subject. 
Each subject who fulfilled the inclusion 
and exclusion criteria, blood sample was 
collected for analysis. Blood glucose level 
was estimated by glucose oxidase-peroxidase 
method, cholesterol was estimated by 
cholesterol oxidase-peroxidase method, 
high density lipoprotein-cholesterol (HDL-
cholesterol) was estimated by the glycerol-3-
phosphate oxidase-peroxidase-N-methyanilin 
propan-sulphonate sodic method and 
triglyceride was estimated by GPO-POD-
ESPT method using auto analyzer. Serum CRP, 
TNF-α, IL-6, resistin and insulin levels were 
measured using ELISA method. The insulin 
resistance was estimated by the HOMA-IR 
index calculation as follow : (insulin (µU/
mL) x [glucose(mmol/L)/22.5]. Subjects were 
considered having insulin resistance if HOMA 
IR value >2.0.10 
Statistical analysis
Data of obese and non obese groups were 
presented as mean ± standard deviation (SD) 
and analyzed by student t test. The statistical 
analysis was considered significant if p value 
<0.05. 
RESULTS
One hundred and twenty subjects 
consisting 60 obese and 60 non obese were 
involved in this study. The characteristics 
of subjects are presented in TABLE 1. 
Significantly higher in the body weight, BMI, 
waist/hip ratio and diastolic blood pressure 
between obese and non obese groups were 
observed in this study (p<0.05). The higher 
waist circumference value in the obese group 
compared to non obese group indicated that 
they have abdominal obesity. 
TABLE 1. Characteristic of subjects (mean ± SD).




Age (year) 21.1 ± 2.8 20.9 ± 3.7 0.170
Body weight (kg) 83.9 ± 14.6 53.4 ± 8.1 0.000
Height (m) 1.627 ± 0.079 1.607 ± 0.068 0.147
BMI (kg/m2) 31.5 ± 3.5 20.6 ± 2.3 0.000
Waist circumference (cm) 96.7 ± 11.3 72.3 ± 7.8 0.000
Hip circumference (cm) 110.7 ± 8.3 89.3 ± 6.9 0.000
Waist/hip ratio 0.872 ± 0.069 0.812 ± 0.082 0.000
Systolic blood pressure (mmHg) 113.8 ± 10.7 111.9 ± 10.7 0.333
Diastolic blood pressure (mmHg) 76.3 ± 7.5 73.3 ± 8.7 0.050
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TABLE 2 showed lipid profile and HOMA 
IR value of obese and non obese groups. 
Significantly higher in the blood glucose and 
insulin levels as well as HOMA IR value 
in the obese group compared to non obese 
group were observed in this study (p<0.05). 
Moreover, significantly higher in triglyceride 
level and significantly lower in HDL-
cholesterol level in obese group compared to 
non obese group were also reported (p<0.05).
TABLE 2.  Level blood glucose, insulin, HOMA IR and lipid profile (mean ± SD) in 
obese and non obese groups
Variable Obese Non obese p
Blood glucose (mg/dL) 85.4 ± 29.1 71.6 ± 19.6 0.003
Insulin (µL U/mL) 33.19 ± 22.00 16.27 ± 14.61 0.000
HOMA-IR 3.63 ± 3.11 1.53 ± 1.49 0.000
Cholesterol (mg/dL) 156.6 ± 32.2 170.6 ± 19.6 0.121
Triglyceride (mg/dL) 143.4 ± 26.1 120.0 ± 22.9 0.000
HDL-cholesterol (mg/dL) 35.39 ± 11.35 54.62 ± 15.51 0.000
LDL-choleserol (mg/dL) 92.52 ± 29.29 91.61 ± 65.57 0.921
TABLE 3 showed adipokines level in 
obese and non obese groups. Significantly 
higher in CRP and resistin levels in obese 
group compared to non obese group were 
observed (p<0.05). In contrast, no significantly 
different in TNF-α and IL-6 in both groups 
were reported.
TABLE 3.  Level of CRP, TNF-α, IL-6 and resistin (mean ± SD) in obese and non obese subjects
Variable Obese Non obese p
CRP (mg/L) 1.543 ± 0.976 1.044 ± 0.256 0.000
TNF-α (pg/mL) 58.32 ± 97.52 59.43 ± 53.52 0.939
IL-6 (pg/mL) 6.19 ± 8.59 8.75 ± 7.77 0.089
Resistin (pg/mL) 1,552.6 ± 306.3 1,250.0 ± 288.9 0.000
DISCUSSION
Obesity is associated with a low-grade 
inflammatory process in the white adipose 
tissue (WAT) that leads to increase of 
circulation of inflammatory markers such as 
IL-6, CRP, and TNF-α. In this study (TABLE 
2), significantly higher blood glucose, insulin, 
triglyceride levels and HOMA-IR value in 
the obese subjects compared with those in 
non obese subjects were found. In contrast, 
significantly lower HDL-cholesterol in the 
obese subjects compared with those in non 
obese subjects were found. In addition, 
significantly higher in CRP and resistin levels 
in the obese subjects compared with those in 
non obese subjects were also found (TABLE 
3). 
Increases of these inflammation markers 
are caused by two phases. In the first phase, the 
fat tissue of obese patients becomes resistant 
to insulin because of the effects of several 
adipokines. In the second stage, this resistance 
occurs in other tissues and leads to increased 
levels of glucose and insulin. This increasing, 
together with increased levels of adipokines 
as clinical conditions due to obesity increase 
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oxidative stress, endothelial dysfunction, 
blood pressure and disorders of lipoprotein 
metabolism, all of which are harmful to 
health.10 Inflammation of the WAT is due to 
obesity because macrophage infiltration is 
caused by the development of tissue mass.12,13 
Other pathways of increasing levels of 
adipokines occur in response to hypoxia, 
because the mass of WAT expands in obesity, 
and as a result, the adipocytes become further 
from the blood vessels causing a relative 
lack of oxygen. Hypoxia then causes the 
stimulation of production and release of 
inflammatory cytokines, chemokines and 
angiogenic factors to stimulate blood flow 
and improve vascularization.14 Adipokine 
secretion is activated by extracellular and 
intracellular stress. Among the extracellular 
factors, free fatty acid (FFA) is a primary 
inductor of these pathways15,16 and in the obese, 
chronically FFA increases. Innate immunity 
receptors, such as toll-like receptor-4 and -2 
(TLR-4 and -2), expressed in WAT (mainly 
by adipocytes, preadipocytes, macrophages 
and endothelial cells) are involved in the 
inflammatory process associated with obesity. 
FFA and other molecules produced by 
hypoxic conditions during obesity activate 
these receptors, particularly TLR4.17,18 
FFA also activate macrophages, especially 
CD11c+, through TLR-4, exacerbating pro-
inflammatory activity.19,20 
The CRP levels in obese group in this 
study was significantly higher than that in non 
obese groups. This result is consistent with 
other previous research findings. CRP levels 
were associated with decreased levels of 
HDL-cholesterol and insulin resistance, and 
increased BMI, waist circumference, blood 
pressure, triglyceride, blood glucose, insulin, 
HOMA-β. In addition, HOMA-IR showed a 
significant correlation between CRP levels 
and metabolic syndrome, including adiposity, 
hyperinsulinemia and insulin resistance.4,21,22 
Recent research shows that there is a strong 
correlation between fasting insulin with CRP 
levels.23 In women, the increase of CRP levels 
are correlated with the increase of fat mass.24
In this study, significantly higher resistin 
levels in the obese group compared with that 
non obese group were found. Miyamoto et 
al.25 reported that subjects with premature 
atherosclerosis have higher plasma resistin 
levels compared with subjects with established 
atherosclerosis. In addition, increased resistin 
expressions were found in type 2 DM, insulin 
resistance and obesity.26,27 However, Norata 
et al.28 failed to detect any change in resistin 
levels in atherosclerotic conditions. Resistin 
may increase the susceptibility of metabolic 
syndrome by regulating adiponectin secretion 
from adipocytes and enhancing hepatic 
gluconeogenesis by inhibiting the enzymes 
involved in gluconeogenesis through AMP-
activated protein kinase activation.29
In this study, no significantly different 
in the IL-6 and TGF-α levels in obese group 
compared with those in non obese group 
were found. This result is similar with other 
previous study.30  Although IL-6 appears to 
be increasing in obesity and decreased in 
response to weight loss, our results showed 
no significantly different at baseline or in 
response to diet. Subcutaneous adipose tissue 
is estimated to release about 30% more IL-6 
in systemic and visceral adipose tissue. 
However, small changes of IL-6 level in obese 
subjects show the levels of IL-6 in obesity 
only about 10% of total IL-6 that is produced 
by fat cells.31 
Some reports indicated that in metabolic 
syndrome patients, the IL-6 levels increased 
with BMI, however its mechanism is still 
unclear. In this study, the TNF-α levels were 
not significantly associated with body weight, 
waist circumference, or percentage of body 
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fat at baseline. These results are in contrast to 
previous study showing the TNF-α level were 
associated with obesity.32 In addition, TNF-α 
levels did not show a significantly decline in 
response to weight loss or diet. They were 
not significantly different after the weight 
loss of 7.5% at 10 weeks. It is indicated that 
adipose tissue has only a small effect on the 
regulation of TNF-α levels. Furthermore, it is 
reported that TNF-α appears to act locally in 
human fat tissue33 and it is not secreted from 
adipose tissue into the blood. Previous study 
indicated changes in IL-6 or TNF-α after 
weight loss (5-9 kg) with dietary intervention 
and exercise.34 Changes in IL-6 and TNF-α 
were significantly correlated with a weight 
loss diet for nine months in the group with 
low calorie diet.30 This result may explain 
the relationship between IL-6 and TNF-α 
in which IL-6 provides proinflammatory 
activity and increases the TNF-α levels. This 
possibility shows that although the weight loss 
did not improve the IL-6 and TNF-α in the 
circulation, there appears to be a significant 
clinical response demonstrating weight loss 
gives a reduction in inflammation. High levels 
of TNF-α are also seen in metabolic syndrome 
patients.35 The relationship between high 
levels of TNF-α and metabolic syndrome is 
associated with TNF-inducing NH2-terminal 
kinase c-jun to mediate phosphorylation of 
IRS-1 serine. This relationship determines the 
normal inhibition of tyrosine phosphorylation 
of IRS-1 and insulin signaling.36
CONCLUSION
In conclusion, the CRP and resistin levels 
as well as insulin resistance are higher in 
obese Javanese population compared to those 
non obese. Further genotype study to identify 
hereditary factors that may contribute to insulin 
sensitivity and resistance are recommended.
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